Miltefosine in the treatment of cutaneous leishmaniasis caused by Leishmania braziliensis in Brazil: a randomized and controlled trial (Q33784151)

29 July 2017

Miltefosine in the treatment of cutaneous leishmaniasis caused by Leishmania braziliensis in Brazil: a randomized and controlled trial (English)

1 reference

29 July 2017

0 references

Leishmania braziliensis

0 references

miltefosine

0 references

Brazil

0 references

cutaneous leishmaniasis

1 reference

Paulo R Machado

1

1 reference

29 July 2017

Julia Ampuero

2

1 reference

29 July 2017

Luiz H Guimarães

3

1 reference

29 July 2017

Leonardo Villasboas

4

1 reference

29 July 2017

Ana T Rocha

5

1 reference

29 July 2017

Albert Schriefer

6

1 reference

29 July 2017

Rosana S Sousa

7

1 reference

29 July 2017

Anette Talhari

8

1 reference

29 July 2017

Gerson Penna

9

1 reference

29 July 2017

Edgar M Carvalho

10

1 reference

29 July 2017

language of work or name

English

0 references

publication date

21 December 2010

1 reference

PLoS Neglected Tropical Diseases

29 July 2017

1 reference

29 July 2017

4

1 reference

29 July 2017

e912

1 reference

29 July 2017

12

1 reference

Creative Commons Attribution 2.5 Generic

29 July 2017

0 references

on focus list of Wikimedia project

ScienceSource

0 references

cites work

Atypical manifestations of tegumentary leishmaniasis in a transmission area of Leishmania braziliensis in the state of Bahia, Brazil

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3006132

Association of treatment of American cutaneous leishmaniasis prior to ulcer development with high rate of failure in northeastern Brazil

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3006132

Mucosal leishmaniasis: epidemiological and clinical aspects

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3006132

Oral miltefosine for Indian visceral leishmaniasis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3006132

Comparison of cutaneous leishmaniasis due to Leishmania (Viannia) braziliensis and L. (V.) guyanensis in Brazil: therapeutic response to meglumine antimoniate.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3006132

Epidemiology of American cutaneous leishmaniasis due to Leishmania braziliensis braziliensis.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3006132

Disseminated Leishmaniasis: A New and Emerging Form of Leishmaniasis Observed in Northeastern Brazil

28 July 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PNTD.0000912

Miltefosine for new world cutaneous leishmaniasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PNTD.0000912

Multiclonal Leishmania braziliensis population structure and its clinical implication in a region of endemicity for American tegumentary leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PNTD.0000912

Influence of Leishmania (Viannia) species on the response to antimonial treatment in patients with American tegumentary leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PNTD.0000912

Efficacy of miltefosine for Bolivian cutaneous leishmaniasis.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3006132

Resistance to antimony and treatment failure in human Leishmania (Viannia) infection

30 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21200420

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Influence of helminth infections on the clinical course of and immune response to Leishmania braziliensis cutaneous leishmaniasis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21200420

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

A low-dose antimony treatment in 159 patients with American cutaneous leishmaniasis: extensive follow-up studies (up to 10 years)

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21200420

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1371/JOURNAL.PNTD.0000912

1 reference

29 July 2017

1 reference

29 July 2017

1 reference